Opinion: Tips for making it through the rest of the Zoom era
By Gerhard Apfelthaler After a full year of taking meetings, interviewing candidates, attending conferences, teaching classes or attending seminars via Zoom or similar online platforms, we all know: Zoom fatigue is real, and it is awful. While we are all thankful for videoconferencing technology, most of us have experienced that a regular eight-hour day on Read More →
Read More →Opinion: Don’t tax California’s family businesses to death
By Ken Monroe In recent months, there’s been a lot of attention paid to some high-profile California businesses that have decided to move some or all of their operations to lower-cost states. Oracle, the second largest software maker in the world, is moving its corporate headquarters from Silicon Valley to Austin, while Hewlett Packard Enterprise—whose Read More →
Read More →Letter to the Editor: We can’t become numb to the horror of mass shootings
Dear Editor: Thank you for writing this article, Henry (“Measuring time by massacres, from Columbine to Boulder,” March 26). You are right that it is horrific to measure time by mass shootings. I am a journalist as well. We have had two mass shootings in our family now, one where Micayla was murdered in the Read More →
Read More →Cal Poly economic impact estimated at $1.8B
Cal Poly, San Luis Obispo is responsible for more than $1.8 billion per year in industrial activity and nearly 20,000 jobs around the state, according to a new study commissioned by the California State University system. The study looked at the 2018-19 academic year and was released April 1, and conducted by a Virginia consulting Read More →
Read More →Region’s clinics get almost $60M in federal COVID funds
Several Central Coast health centers are getting nearly $60 million in total federal funds to help expand access to COVID-19 vaccines, testing and treatment because of the American Rescue Plan. Of the six centers, Community Health Centers of the Central Coast, which is based in Nipomo, received the most money, with $18.7 million. Three organizations Read More →
Read More →Revenues and losses both grew at Cure in 2020
Cure Pharmaceutical, an Oxnard company with a CBD products subsidiary, reported steep revenue growth but rising net losses in the fourth quarter and full year of 2020. In an annual statement released April 1, Cure reported revenue of $2.1 million in the final quarter of 2020, up 229% from the same quarter a year before. Read More →
Read More →